Top-News
Gesundheitswesen USA

G1 Therapeutics News

Aktie
WKN:  A2DR0J ISIN:  US3621LQ1099 US-Symbol:  GTHX
3,90 €
+0,12 €
+3,17%
24.05.24 20:36:43
Handeln Depot/Watchlist
Aktienanzahl *
51,75 Mio.
Marktkapitalisierung *
194,93 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 16.10.2023

G1 Therapeutics News

09.02.23 - PR Newswire
First Prescription for COSELA® (trilaciclib) Issued in China
First Prescription for COSELA® (trilaciclib) Issued in China PR Newswire
15.10.21 - PR Newswire
Thinking about buying stock in Limelight Networks, G1 Therapeutics, Allegheny Technologies, Marathon Digital, or Nextplay Technologies?
Thinking about buying stock in Limelight Networks, G1 Therapeutics, Allegheny Technologies, Marathon Digital, or Nextplay Technologies? PR Newswire
16.02.21 - PR Newswire
Thinking about buying stock in G1 Therapeutics, Strongbridge Biopharma, Soligenix, Pieris Pharmaceuticals, or Diffusion Pharmaceuticals?
Thinking about buying stock in G1 Therapeutics, Strongbridge Biopharma, Soligenix, Pieris Pharmaceuticals, or Diffusion Pharmaceuticals? PR Newswire
02.02.21 - PR Newswire
Thinking about trading options or stock in Pfizer, Daqo New Energy, Horizon Therapeutics, Intel Corp, or G1 Therapeutics?
Thinking about trading options or stock in Pfizer, Daqo New Energy, Horizon Therapeutics, Intel Corp, or G1 Therapeutics? PR Newswire
30.11.20 - PR Newswire
Thinking about trading options or stock in Tesla, G1 Therapeutics, Apple, Micron Technology, or At Home Group?
Thinking about trading options or stock in Tesla, G1 Therapeutics, Apple, Micron Technology, or At Home Group? PR Newswire
14.01.20 - PR Newswire
Quantum Leap Healthcare Collaborative and G1 Therapeutics Announce the Selection of Trilaciclib in the I-SPY 2 TRIAL for Breast Cancer
Quantum Leap Healthcare Collaborative and G1 Therapeutics Announce the Selection of Trilaciclib in the I-SPY 2 TRIAL for Breast Cancer PR Newswire

Newssuche

Videos

newspaper
27.05.24 -2,54%
Technical Trading: Copper Short Chance
Copper Short Typ: Turbo Open End WKN: VQ7PJR Hebel: 9,92 Laufzeit: OpenEnd Einstieg: Market ... Mehr »